Transcription factors in the nuclear factor ?B (NF-?B) family are evolutionarily conserved master regulators of immune and inflammatory responses. They are activated in response to ligation of many receptors including T-cell receptors, B-cell receptors, members of the tumor necrosis factor (TNF) receptor superfamily and the Toll-like receptor/interleukin-1 receptor (TLR/IL-1R) superfamily. The I?B kinase (IKK), comprising IKK? and IKK?, is at the heart of NF-?B activation and mediates two NF-?B activation pathways. The canonical NF-?B pathway is triggered by microbial and viral infections and pro-inflammatory cytokines and is dependent on IKK? phosphorylation and activation. The alternative pathway is triggered by certain members of the TNF cytokine family and selectively activates IKK?. Activated IKK phosphorylates I?Bs, leading to their polyubiquitination and subsequent degradation by the proteasome. The freed NF-?B dimers translocate to the nucleus to mediate transcription. Because of its importance in NF-?B activation, IKK, especially IKK?, has become a potential therapeutic target for many human diseases. The regulatory protein NEMO (also known as IKK? or FIP-3) interacts with IKK? and/or IKK? to form the IKK?, IKK? or IKK?/? holo-complex. The intact IKK? holo-complex is approximately 700-900kD in molecular mass containing multiple copies of IKK? and NEMO. IKK? and IKK? both contain the following conserved recognizable domains: a kinase domain (KD), a leucine zipper domain (LZ), a helix loop helix domain (HLH) and a C-terminal NEMO-binding domain (NBD). NEMO contains an N-terminal kinase-binding domain (KBD), a minimal oligomerization domain (MOD) that is also the ubiquitin binding domain (UBD) and a C-terminal zinc finger domain (ZF). IKK and NF-?B signaling has attracted tremendous attention with more than 30,000 papers published on the subject. Despite the biological importance, not a single successful structure determination has been reported on IKK, an indication on the difficulty of the project. To elucidate the molecular basis of IKK function and to assist the discovery of IKK inhibitors, we propose a series of structural and functional studies on IKK, in particular, IKK? and its regulatory protein NEMO.
The I?B kinase (IKK) is at the heart of NF-?B activation and a potential therapeutic target for many human diseases. The proposal seeks structural studies of IKK, which will enhance our understanding on the molecular basis of IKK function. In addition, the proposed studies will provide a structural basis for discovery and optimization of IKK inhibitors in the treatment of inflammatory diseases and cancer.
|Wu, Hao (2013) Higher-order assemblies in a new paradigm of signal transduction. Cell 153:287-92|
|Napetschnig, Johanna; Wu, Hao (2013) Molecular basis of NF-ÎºB signaling. Annu Rev Biophys 42:443-68|
|Ferrao, Ryan; Li, Jixi; Bergamin, Elisa et al. (2012) Structural insights into the assembly of large oligomeric signalosomes in the Toll-like receptor-interleukin-1 receptor superfamily. Sci Signal 5:re3|
|Zheng, Chao; Yin, Qian; Wu, Hao (2011) Structural studies of NF-ÎºB signaling. Cell Res 21:183-95|
|Xu, Guozhou; Lo, Yu-Chih; Li, Qiubai et al. (2011) Crystal structure of inhibitor of ÎºB kinase Î². Nature 472:325-30|
|Wu, Hao; Lo, Yu-Chih; Yin, Qian (2011) Structural studies of NEMO and TRAF6: implications in NF-ÎºB activation. Adv Exp Med Biol 691:89-91|
|Wu, Hao; Lo, Yu-Chih; Lin, Su-Chang (2010) Recent advances in polyubiquitin chain recognition. F1000 Biol Rep 2:1-5|